Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 82.59 | 44.74 |
PEG Ratio (TTM) | 0.43 | 0.47 |
P/S Ratio (TTM) | 4.52 | 7.16 |
P/B Ratio (TTM) | 4.39 | 42.82 |
P/FCF Ratio (TTM) | 39.67 | 35.51 |
Price to 5YR AVG Earnings Ratio | 80.50 | 33.01 |
Price to 5YR AVG FCF Ratio | 44.79 | 49.70 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.03% | 10.33% |
ROE (TTM) | 5.45% | 97.67% |
Net Profit Margin (TTM) | 5.46% | 16.03% |
ROIC 5YR AVG | 6.83% | 15.50% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 276.81% | 9.45% | -36.49% |
Revenue | 2.92% | 8.62% | 10.89% |
Net Income | 274.27% | 10.77% | -34.65% |
Cash Flow | 104.34% | 14.60% | 19.55% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.68 | 1.28 |
Quick Ratio (TTM) | 1.68 | 1.28 |
D/E Ratio (TTM) | 1.23 | 4.07 |
Interest Coverage (TTM) | 2.53 | 8.19 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.55 | 5.54 |
LTL to 5YR AVG FCF | 12.89 | 7.71 |
Shares Outstanding Growth 5YR AVG | 0.94% | -0.83% |